Cytoskeletal organization in tropomyosin-mediated reversion of ras-transformation:: Evidence for Rho kinase pathway

被引:38
作者
Shah, V
Bharadwaj, S
Kaibuchi, K
Prasad, GL
机构
[1] Wake Forest Univ, Bowman Gray Sch Med, Dept Gen Surg, Winston Salem, NC 27157 USA
[2] Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Winston Salem, NC 27157 USA
[3] Wistar Inst Anat & Cell Biol, Philadelphia, PA USA
[4] Nara Inst Sci & Technol, Ikoma, Japan
关键词
tropomyosin; cytoskeleton; Rho kinase;
D O I
10.1038/sj.onc.1204291
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tropomyosin (TM) family of cytoskeletal proteins is implicated in stabilizing actin microfilaments. Many TM isoforms, including tropomyosin-1 (TM1), are downregulated in transformed cells. Previously we demonstrated that TM1 is a suppressor of the malignant transformation, and that TM1 reorganizes microfilaments in the transformed cells, To investigate how TM1 induces microfilament organization in transformed cells, we utilized uas-transformed NIH3T3 (DT) cells, and those transduced to express TM1, and/or TM2, Enhanced expression of TM1 alone, but not TM2, results in re-emergence of microfilaments; TM1, together with TM2 remarkably improves microfilament architecture. TM1 induced cytoskeletal reorganization involves an enhanced expression of caldesmon, but not vinculin, alpha -actinin, or gelsolin, In addition, TM1-induced cytoskeletal reorganization and the revertant phenotype appears to involve re-activation of RhoA controlled pathways in DT cells. RhoA expression, which is suppressed in DT cells, is significantly increased in TM1-expressing cells, without detectable changes in the expression of Pac or Cdc42, Furthermore, expression of a dominant negative Rho kinase, or treatment with Y-27632 disassembled microfilaments in normal NIH3T3 and in TM1 expressing cells. These data suggest that reactivation of Rho kinase directed pathways are critical for TM1-mediated microfilament assemblies.
引用
收藏
页码:2112 / 2121
页数:10
相关论文
共 57 条
[31]   Rho-associated kinase, a novel serine threonine kinase, as a putative target for the small GTP binding protein Rho [J].
Matsui, T ;
Amano, M ;
Yamamoto, T ;
Chihara, K ;
Nakafuku, M ;
Ito, M ;
Nakano, T ;
Okawa, K ;
Iwamatsu, A ;
Kaibuchi, K .
EMBO JOURNAL, 1996, 15 (09) :2208-2216
[32]  
MATSUMURA F, 1983, J BIOL CHEM, V258, P3954
[33]   Caldesmon [J].
Matsumura, Fumio ;
Yamashiro, Shigeko .
CURRENT OPINION IN CELL BIOLOGY, 1993, 5 (01) :70-76
[34]   Epigenetic regulation of gelsolin expression in human breast cancer cells [J].
Mielnicki, LM ;
Ying, AM ;
Head, KL ;
Asch, HL ;
Asch, BB .
EXPERIMENTAL CELL RESEARCH, 1999, 249 (01) :161-176
[35]   Functional involvement of serum response factor in the transcriptional regulation of caldesmon gene [J].
Momiyama, T ;
Hayashi, K ;
Obata, H ;
Chimori, Y ;
Nishida, T ;
Ito, T ;
Kamiike, W ;
Matsuda, H ;
Sobue, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 242 (02) :429-435
[36]   Activation of serum response factor by RhoA is mediated by the nuclear factor-κB and C/EBP transcription factors [J].
Montaner, S ;
Perona, R ;
Saniger, L ;
Lacal, JC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (13) :8506-8515
[37]   A balance of signaling by Rho family small GTPases RhoA, Rac1 and Cdc42 coordinates cytoskeletal morphology but not cell survival [J].
Moorman, JP ;
Luu, D ;
Wickham, J ;
Bobak, DA ;
Hahn, CS .
ONCOGENE, 1999, 18 (01) :47-57
[38]   Rho effectors and reorganization of actin cytoskeleton [J].
Narumiya, S ;
Ishizaki, T ;
Watanabe, N .
FEBS LETTERS, 1997, 410 (01) :68-72
[39]   IN-VITRO FUNCTIONAL-CHARACTERIZATION OF BACTERIALLY EXPRESSED HUMAN FIBROBLAST TROPOMYOSIN ISOFORMS AND THEIR CHIMERIC MUTANTS [J].
NOVY, RE ;
SELLERS, JR ;
LIU, LF ;
LIN, JJC .
CELL MOTILITY AND THE CYTOSKELETON, 1993, 26 (03) :248-261
[40]  
NOVY RE, 1991, J BIOL CHEM, V266, P16917